HDL3 exerts more powerful anti-oxidative, protective effects against copper-catalyzed LDL oxidation than HDL2

Clinical Biochemistry

Volumn 30, Issue 3, 1997, Pages 221-225

  Yoshikawa, Masae ^a   Sakuma, Nagahiko ^a   Hibino, Takeshi ^a   Sato, Takaaki ^a   Fujinami, Takao ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

electrophoretic mobility; high density lipoprotein 3; high density lipoprotein 2; lipid hydroperoxide; oxidized low density lipoprotein

Indexed keywords

COPPER; HIGH DENSITY LIPOPROTEIN; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; PHOSPHATE; SODIUM CHLORIDE; ANTIOXIDANT; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 3; LIPID PEROXIDE;

AGAR GEL ELECTROPHORESIS; ARTICLE; ATHEROSCLEROSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; ELECTROPHORETIC MOBILITY; HUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; CATALYSIS; METABOLISM; OXIDATION REDUCTION REACTION;

ANTIOXIDANTS; CATALYSIS; COPPER; ELECTROPHORESIS, AGAR GEL; HUMANS; LIPID PEROXIDES; LIPOPROTEINS, HDL; LIPOPROTEINS, HDL2; LIPOPROTEINS, HDL3; LIPOPROTEINS, LDL; OXIDATION-REDUCTION;

EID: 0030612086     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(97)00031-3     Document Type: Article

References (30)

1. Kannel WB, Castelli WP, Gordon T, Mcnamara PM. Serum cholesterol, lipoproteins, and risk of heart diseases. The Framingham Study. Ann Intern Med 1971; 74: 1-12.
2. Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis 1983; 3: 149-59.
3. Morel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984; 4: 357-64.
4. Quinn MT, Parthasarathy S, Steinberg D. Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein. Proc Natl Acad Sci USA 1985; 82: 5949-53.
5. Quinn M, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/ macrophages during atherogenesis. Proc Natl Acad Sci USA 1987; 84: 2995-98.
6. Steinberg D, Parthsarathy S, Carew TE, Khoo JA, Witztum JL. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-24.
7. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. Am J Med 1977; 62: 707-14.
8. Marques-Vidal P, Ruidavets JB, Cambou JP, et al. Distribution, fatty acid composition and apolipoprotein A-I immunoreactivity of high density lipoprotein subfractions in myocardial infarction. Atherosclerosis 1995; 112: 29-38.
9. Chander R, Kapoor NK. High density lipoprotein is a scavenger of superoxide anions. Biochem Pharmacol 1990; 40: 1663.
10. Klimov AN, Nikiforova AA, Pleskov VM, et al. The protective action of high-density lipoproteins, their subfractions, and lecithin-cholesterol acyltransferase in the peroxide modification of low density lipoproteins. Biokhimiya 1989; 54: 118-23.
11. Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1990; 1044: 275-83.
12. Mackness MI, Durrington PN. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis 1995; 115: 234-53.
13. Eisenberg S. High density lipoprotein metabolism. J Lipid Res 1984; 25: 1017-58.
14. Sakuma N, Cui L, Matumoto Y, et al. Changes of HDL subfraction concentration and particle size by intralipid in vivo. Atherosclerosis 1988; 74: 91-8.
15. Klimov AN, Gurevich VS, Nikiforova AA, et al. Anti-oxidative activity of high density lipoproteins in vivo. Atherosclerosis 1993; 100: 13-18.
16. Kappus H. Lipid peroxidation: mechanisms, analysis, enzymology and biological relevance. In: Oxidative Stress. Ed. Sies H., Pp. 273-310. London: Academic Press, 1985.
17. Jurgens G, Hoff HF, Chisolm GM, Esterbauer H. Modification of human serum low density lipoprotein by oxidation-characterization and pathophysiological implications. Chem. Phys. Lipids 1987; 45: 315-36.
18. Esterbauer H, Jurgens G, Quenhenberger O, Koller E. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res 1987; 28: 495-509.
19. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345-53.
20. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bincinchonic acid. Anal Biochem 1985; 150: 76-85.
21. Steinbrecher UP, Witztum JL, Parthasarathy S, Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Arteriosclerosis 1987; 7: 135-43.
22. Ohishi N, Ohkawa H, Miike A, Yagi K. A new assay method for lipid peroxides using a methylene blue derivative. Biochem Int 1985; 10: 205-11.
23. Kuzuya M, Naito M, Funaki C, et al. Lipid peroxide and transition metals are required for the toxicity of oxidized low density lipoprotein to cultured endothelial cells. Biochim Biophys Acta 1991; 1096: 155-61.
24. Chait A. Methods for assessing lipid and lipoprotein oxidation. Curr Opin Lipidol 1992; 3: 389-94.
25. Jialal I, Devaraj S. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective. Clin Chem 1996; 42: 4:498-506.
26. Esterbauer H, Rotheneder MD, Waeg G, Striegl G, Jurgens G. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol 1990; 3: 78-92.
27. Mackness MI, Abbott C, Arrol S, Durrington PN. The role of high-density lipoprotein and lipid-soluble anti-oxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem J 1993; 294: 829-34.
28. Hahn M, Subbiah MTR. Significant association of lipid peroxidation products with high density lipoproteins. Biochem Mol Biol Int 1994; 33(4): 699-704.
29. Mackness MI, Arrol S, Abbott C, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993; 104: 129-35.
30. Stafforini DM, Zimmerman GA, McIntyre TM, Prescott SM. The plasma PAF acetylhydrolase prevents oxidative modification of low density lipoprotein. J Lipid Mediat Cell Signal 1994; 10: 53-6.